Paul E Greenberg

Paul E Greenberg

UNVERIFIED PROFILE

Are you Paul E Greenberg?   Register this Author

Register author
Paul E Greenberg

Paul E Greenberg

Publications by authors named "Paul E Greenberg"

Are you Paul E Greenberg?   Register this Author

35Publications

477Reads

27Profile Views

Medicaid spending burden among beneficiaries with treatment-resistant depression.

J Comp Eff Res 2019 Apr 8;8(6):381-392. Epub 2019 Feb 8.

Analysis Group, Inc, Boston, MA, 02199, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer-2018-0140DOI Listing
April 2019

The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

J Clin Psychiatry 2015 Feb;76(2):155-62

Analysis Group, Inc, 111 Huntington Ave, 10th Floor, Boston, MA 02199

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.14m09298DOI Listing
February 2015

Cost of illness: an ongoing battle worth fighting.

Authors:
Paul E Greenberg

Pharmacoeconomics 2014 Dec;32(12):1151-2

Analysis Group, Inc., Boston, MA, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs40273-014-02
Web Search
http://link.springer.com/10.1007/s40273-014-0217-z
Publisher Site
http://dx.doi.org/10.1007/s40273-014-0217-zDOI Listing
December 2014

Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.

J Clin Psychiatry 2013 Jun 19;74(6):568-75. Epub 2013 Apr 19.

Analysis Group, Inc, 111 Huntington Ave, 10th Fl, Boston, MA 02199, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.12r08167DOI Listing
June 2013

Confounding factors in off-label drug use.

Health Aff (Millwood) 2012 Feb;31(2):460; author reply 460

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2011.1394DOI Listing
February 2012

Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopram.

Am Health Drug Benefits 2011 Mar;4(2):78-87

Vice President, Global Health Economics and Outcomes Research, Forest Research Institute, at the time of the study.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106579PMC
March 2011

Introducing perspectives on comparative effectiveness research.

Pharmacoeconomics 2010 ;28(10):787-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11535820-000000000-00000DOI Listing
December 2010

The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.

Expert Opin Pharmacother 2009 Oct;10(14):2317-28

Analysis Group, Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656560903140525DOI Listing
October 2009

Does generic substitution always make sense?

Authors:
Paul E Greenberg

J Med Econ 2008 ;11(3):547-53

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3111/13696990802371075DOI Listing
June 2009

Antidepressant treatment patterns and costs among US employees.

J Med Econ 2009 Mar;12(1):36-45

Analysis Group, Inc., Boston, MA 02199, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3111/13696990902757389DOI Listing
March 2009

Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population.

Curr Med Res Opin 2008 Sep 31;24(9):2587-95. Epub 2008 Jul 31.

Analysis Group, Inc., Boston, MA 02199, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007990802303525DOI Listing
September 2008

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.

Arch Gen Psychiatry 2007 May;64(5):543-52

Intramural Research Program, Section on Developmental Genetic Epidemiology, National Institute of Mental Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archpsyc.64.5.543DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1931566PMC
May 2007

Considering the costs of bipolar depression.

Behav Healthc 2007 Jan;27(1):45-7

Harvard Medical School, USA.

View Article

Download full-text PDF

Source
January 2007

The economic burden of depression in the US: societal and patient perspectives.

Expert Opin Pharmacother 2005 Mar;6(3):369-76

Analysis Group, Inc., 111 Huntington Ave., 10th Floor, Boston, MA 02199, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14656566.6.3.369
Publisher Site
http://dx.doi.org/10.1517/14656566.6.3.369DOI Listing
March 2005

Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently.

J Rheumatol 2004 Aug;31(8):1621-9

Eli Lilly and Company, Indianapolis, Indiana 46285, USA.

View Article

Download full-text PDF

Source
August 2004

Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis.

J Clin Psychiatry 2003 Oct;64(10):1201-9

Analysis Group, Inc., 111 Huntington Avenue, Boston, MA 02466, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v64n1010DOI Listing
October 2003

The economic burden of depression with painful symptoms.

J Clin Psychiatry 2003 ;64 Suppl 7:17-23

Analysis Group/Economics, Inc., Boston, MA 02199, USA.

View Article

Download full-text PDF

Source
July 2003

Economic cost and epidemiological characteristics of patients with fibromyalgia claims.

J Rheumatol 2003 Jun;30(6):1318-25

Eli Lilly and Company, Indianapolis, Indiana 46285, USA.

View Article

Download full-text PDF

Source
June 2003

The economics of women and depression: an employer's perspective.

J Affect Disord 2003 Mar;74(1):15-22

111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-0327(02)00427-5DOI Listing
March 2003

Economic burden of respiratory infections in an employed population.

Chest 2002 Aug;122(2):603-11

Analysis Group/Economics, Boston, MA 02199, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.122.2.603DOI Listing
August 2002

Identification of a claims data "signature" and economic consequences for treatment-resistant depression.

J Clin Psychiatry 2002 Aug;63(8):717-26

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v63n0810DOI Listing
August 2002

Direct and indirect costs of asthma to an employer.

J Allergy Clin Immunol 2002 Feb;109(2):264-70

Analysis Group/Economics, Cambridge, MA 02138, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/mai.2002.121310DOI Listing
February 2002